Flurbiprofen Sodium Dihydrate is a nonsteroidal anti-inflammatory drug belonging to the phenylalkanoic acid derivative class, widely utilized to manage pain, inflammation, and fever associated with arthritis… Read more
Flurbiprofen Sodium Dihydrate is a nonsteroidal anti-inflammatory drug belonging to the phenylalkanoic acid derivative class, widely utilized to manage pain, inflammation, and fever associated with arthritis and various musculoskeletal disorders. By inhibiting cyclooxygenase enzymes, this compound effectively reduces prostaglandin synthesis. In pharmaceutical research and manufacturing, high-quality reference standards of Flurbiprofen Sodium Dihydrate, along with its related pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds, are critical for rigorous analytical testing. Laboratories rely on these materials for accurate impurity profiling, method validation, and consistent quality control throughout the drug development lifecycle. These specialized analytical tools ensure regulatory compliance by enabling the precise quantification and identification of degradation products or metabolic pathways, supporting the safety and efficacy of the parent drug in clinical applications.